Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Colon Cancer|Lung Cancer|Breast Cancer
Interventions: BIOLOGICAL: AD5 CEA Vaccine
Sponsor: Etubics Corporation
Collaborators: Duke University